Impact of Prophylactic Cranial Irradiation Timing on Brain Relapse Rates in Patients With Stage IIIB None-Small-Cell Lung Carcinoma Treated With Two Different Chemoradiotherapy Regimens


Topkan E., Parlak C., Kotek A., Yuksel O., CENGİZ M., Ozsahin M., ...More

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol.83, no.4, pp.1264-1271, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 83 Issue: 4
  • Publication Date: 2012
  • Doi Number: 10.1016/j.ijrobp.2011.09.031
  • Journal Name: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1264-1271
  • Keywords: Stage IIIB non-small-cell lung carcinoma, Chemoradiotherapy, Prophylactic cranial irradiation, Timing, Brain metastasis incidence, RECURSIVE PARTITIONING ANALYSIS, ONCOLOGY GROUP RTOG, TERM-FOLLOW-UP, NEOADJUVANT CHEMOTHERAPY, FAILURE PATTERNS, CANCER, METASTASES, SURGERY, RISK, TIME
  • Akdeniz University Affiliated: Yes

Abstract

Purpose: To retrospectively assess the influence of prophylactic cranial irradiation (PCI) timing on brain relapse rates in patients treated with two different chemoradiotherapy (CRT) regimens for Stage IIIB non-small-cell lung cancer (NSCLC).